Clinical and functional implications of a history of childhood ADHD in first-episode psychosis

Schizophrenia Research

Volumn 165, Issue 2-3, 2015, Pages 128-133

  Rho, Aldanie ^a   Traicu, Alexandru ^a,b   Lepage, Martin ^b   Iyer, Srividya N ^a,b   Malla, Ashok ^a,b   Joober, Ridha ^a,b  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Attention deficit hyperactivity disorder (ADHD); First episode psychosis (FEP); Long term outcomes; Premorbid functioning; Schizophrenia spectrum disorder (SSD)

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CONDUCT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEGATIVE SYNDROME; ONSET AGE; OUTCOME ASSESSMENT; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SOCIAL INTERACTION; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DEVELOPMENTAL DISABILITIES; FOLLOW UP; PREVALENCE; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84930039018     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.03.031     Document Type: Article

References (45)

1. Andreasen N.C. Scale for the Assessment of Negative Symptoms 1983, University of Iowa, Iowa City.
2. Andreasen N.C. Scale for the Assessment of Positive Symptoms 1983, University of Iowa, Iowa City.
3. Barr W.B. Schizophrenia and attention deficit disorder. Two complex disorders of attention. Ann. N. Y. Acad. Sci. 2001, 931:239-250.
4. Bellak L., Kay S.R., Opler L.A. Attention deficit disorder psychosis as a diagnostic category. Psychiatr. Dev. 1987, 5(3):239-263.
5. Biederman J., Monuteaux M.C., Mick E., Spencer T., Wilens T.E., Silva J.M., Snyder L.E., Faraone S.V. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol. Med. 2006, 36(2):167-179.
6. Biederman J., Newcorn J., Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am. J. Psychiatry 1991, 148:564-577.
7. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8(3):470.
8. Carter J.D., Bizzell J., Kim C., Bellion C., Carpenter K.L., Dichter G., Belger A. Attention deficits in schizophrenia-preliminary evidence of dissociable transient and sustained deficits. Schizophr. Res. 2010, 122(1-3):104-112.
9. Cassidy C.M., Joober R., King S., Malla A.K. Childhood symptoms of inattention-hyperactivity predict cannabis use in first episode psychosis. Schizophr. Res. 2011, 132(2-3):171-176.
10. Charach A., Yeung E., Climans T., Lillie E. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50(1):9-21.
11. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A.M., Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr. Bull. 2003, 29(4):633-651.
12. Dalsgaard S., Mortensen P.B., Frydenberg M., Maibing C.M., Nordentoft M., Thomsen P.H. Association between Attention-Deficit Hyperactivity Disorder in childhood and schizophrenia later in adulthood. Eur. Psychiatry 2014, 29(4):259-263.
13. Dalteg A., Zandelin A., Tuninger E., Levander S. Psychosis in adulthood is associated with high rates of ADHD and CD problems during childhood. Nord. J. Psychiatry 2014, 68(8):560-566.
14. De la Serna E., Baeza I., Toro J., Andres S., Puig O., Sanchez-Guistau V., Romero S., Bernardo M., Castro-Fornieles J. Relationship between clinical and neuropsychological characteristics in child and adolescent first degree relatives of subjects with schizophrenia. Schizophr. Res. 2010, 116(2-3):159-167.
15. Elman I., Sigler M., Kronenberg J., Lindenmayer J., Doron A., Mendlovic S., Gaoni B. Characteristics of patients with schizophrenia successive to childhood attention deficit hyperactivity disorder (ADHD). Isr. J. Psychiatry Relat. Sci. 1997, 35(4):280-286.
16. Eranti S., Maccabe J., Bundy H., Murray R. Gender difference in age at onset of schizophrenia: a meta-analysis. Psychol. Med. 2013, 43(01):155-167.
17. Faraone S.V., Biederman J., Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol. Med. 2006, 36(2):159-165.
18. Faraone S.V., Sergeant J., Gillberg C., Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2(2):104.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, January 1995 FINAL. SCID-I/P Version 2.0 1995, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
20. Gogtay N., Vyas N.S., Testa R., Wood S.J., Pantelis C. Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophr. Bull. 2011, 37(3):504-513.
21. Gomez R.L., Janowsky D., Zetin M., Huey L., Clopton P.L. Adult psychiatric diagnosis and symptoms compatible with the hyperactive child syndrome: a retrospective study. J. Clin. Psychiatry 1981, 42(10):389-394.
22. Hamshere M.L., Stergiakouli E., Langley K., Martin J., Holmans P., Kent L., Owen M.J., Gill M., Thapar A., O'Donovan M., Craddock N. Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia. Br. J. Psychiatry 2013, 203(2):107-111.
23. Hollingshead A.B. Four Factor Index of Social Status 1975.
24. Howes O.D., Kapur S. A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic). Br. J. Psychiatry 2014, 205(1):1-3.
25. Hurtig T.M., Taanila A., Veijola J., Ebeling H., Maki P., Miettunen J., Kaakinen M., Joukamaa M., Therman S., Heinimaa M., Jarvelin M.R., Moilanen I. Associations between psychotic-like symptoms and inattention/hyperactivity symptoms. Soc. Psychiatry Psychiatr. Epidemiol. 2011, 46(1):17-27.
26. Karve S., Cleves M.A., Helm M., Hudson T.J., West D.S., Martin B.C. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr. Med. Res. Opin. 2009, 25(9):2303-2310.
27. Kieling C., Kieling R.R., Rohde L.A., Frick P.J., Moffitt T., Nigg J.T., Tannock R., Castellanos F.X. The age at onset of attention deficit hyperactivity disorder. Am. J. Psychiatr. 2010, 167(1):14-16.
28. Kim S.J., Lee Y.J., Jang J.H., Lim W., Cho I.H., Cho S.J. The relationship between psychotic-like experiences and attention deficits in adolescents. J. Psychiatr. Res. 2012, 46(10):1354-1358.
29. Klein R.G., Mannuzza S., Olazagasti M.A., Roizen E., Hutchison J.A., Lashua E.C., Castellanos F.X. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33years later. Arch. Gen. Psychiatry 2012, 69(12):1295-1303.
30. Kooij S.J.J., Bejerot S., Blackwell A., Caci H., Casas-Brugué M., Carpentier P.J., Edvinsson D., Fayyad J., Foeken K., Fitzgerald M., Gaillac V., Ginsberg Y., Henry C., Krause J., Lensing M.B., Manor I., Niederhofer H., Nunes-Filipe C., Ohlmeier M.D., Oswald P., Pallanti S., Pehlivanidi A., Ramos-Quiroga J.A., Rastam M., Ryffel-Rawak D.R., Stes S., Asherson P. EUropean consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry 2010, 10:67. (Sep 3).
31. Levy A., Traicu A., Iyer S., Malla A., Joober R. Psychotic disorders co-morbid with ADHD: an important knowledge gap. Can. J. Psychiatry 2015, 1;60(3 Suppl 2):S48-52.
32. Malla A., Takhar J.J., Norman R., Manchanda R., Cortese L., et al. Negative symptoms in first-episode non-affective psychosis. Acta Psychiatr. Scand. 2002, 105(6):431-439.
33. Malla A., Norman R., McLean T., Scholten D., Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust. N. Z. J. Psychiatry 2003, 37(4):407-413.
34. Marsh P.J., Williams L.M. ADHD and schizophrenia phenomenology: visual scanpaths to emotional faces as a potential psychophysiological marker?. Neurosci. Biobehav. Rev. 2006, 30(5):651-665.
35. Mehler-Wex C., Riederer P., Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 2006, 10(3-4):167-179.
36. Norman R., Malla A., Verdi M., Hassall L., Fazekas C. Understanding delay in treatment for first-episode psychosis. Psychol. Med. 2004, 34(02):255-266.
37. Oner O., Munir K. Attentional and neurocognitive characteristics of high-risk offspring of parents with schizophrenia compared with DSM-IV attention deficit hyperactivity disorder children. Schizophr. Res. 2005, 76(2-3):293-299.
38. Peralta V., de Jalon E.G., Campos M.S., Zandio M., Sanchez-Torres A., Cuesta M.J. The meaning of childhood attention-deficit hyperactivity symptoms in patients with a first-episode of schizophrenia-spectrum psychosis. Schizophr. Res. 2011, 126(1-3):28-35.
39. Roncero C., Ros-Cucurull E., Daigre C., Casas M. Prevalence and risk factors of psychotic symptoms in cocaine-dependent patients. Actas Esp. Psiquiatr. 2012, 40(4):187-197.
40. Rosen A., HadziPavlovic D., Parker G. The life skills profile. Schizophr. Bull. 1989, 15(2):325-337.
41. Salo R., Fassbender C., Iosif A.M., Ursu S., Leamon M.H., Carter C. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure. Psychiatry Res. 2013, 210(2):529-535.
42. Spitzer R., Gibbon M., Endicott J. Global assessment scale (GAS), global assessment of functioning (GAF) scale, social and occupational functioning assessment scale (SOFAS). Handbook of Psychiatric Measures 2000, 96-100. American Psychiatric Association, Washington.
43. Valenstein M., Copeland L.A., Blow F.C., McCarthy J.F., Zeber J.E., Gillon L., Bingham C.R., Stavenger T. 2002 pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med. Care 2002, 40(8):630-639.
44. Volkow N.D., Wang G.-J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 2007, 64(8):932-940.
45. Williams N.M., Zaharieva I., Martin A., Langley K., Mantripragada K., Fossdal R., Stefansson H., Stefansson K., Magnusson P., Gudmundsson O.O., Gustafsson O., Holmans P., Owen M.J., O'Donovan M., Thapar A. Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet 2010, 376(9750):1401-1408.